Regulated production of free radicals by the mitochondrial electron transport chain: Cardiac ischemic preconditioning

Satoshi Matsuzaki, Pamela A. Szweda, Luke I. Szweda, Kenneth M. Humphries

Research output: Contribution to journalReview article

18 Citations (Scopus)

Abstract

Excessive production of free radicals by mitochondria is associated with, and likely contributes to, the progression of numerous pathological conditions. Nevertheless, the production of free radicals by the mitochondria may have important biological functions under normal or stressed conditions by activating or modulating redox-sensitive cellular signaling pathways. This raises the intriguing possibility that regulated mitochondrial free radical production occurs via mechanisms that are distinct from pathologies associated with oxidative damage. Indeed, the capacity of mitochondria to produce free radicals in a limited manner may play a role in ischemic preconditioning, the phenomenon whereby short bouts of ischemia protect from subsequent prolonged ischemia and reperfusion. Ischemic preconditioning can thus serve as an important model system for defining regulatory mechanisms that allow for transient, signal-inducing, production of free radicals by mitochondria. Defining how these mechanism(s) occur will provide insight into therapeutic approaches that minimize oxidative damage without altering normal cellular redox biology. The aim of this review is to present and discuss evidence for the regulated production of superoxide by the electron transport chain within the ischemic preconditioning paradigm of redox regulation.

Original languageEnglish (US)
Pages (from-to)1324-1331
Number of pages8
JournalAdvanced Drug Delivery Reviews
Volume61
Issue number14
DOIs
StatePublished - Nov 30 2009

Fingerprint

Ischemic Preconditioning
Electron Transport
Free Radicals
Mitochondria
Oxidation-Reduction
Ischemia
Superoxides
Reperfusion
Cell Biology
Pathology

Keywords

  • Cardiac ischemia
  • Electron transport chain
  • Free radicals
  • Mitochondria
  • Oxidation and reduction
  • Preconditioning

ASJC Scopus subject areas

  • Pharmaceutical Science

Cite this

Regulated production of free radicals by the mitochondrial electron transport chain : Cardiac ischemic preconditioning. / Matsuzaki, Satoshi; Szweda, Pamela A.; Szweda, Luke I.; Humphries, Kenneth M.

In: Advanced Drug Delivery Reviews, Vol. 61, No. 14, 30.11.2009, p. 1324-1331.

Research output: Contribution to journalReview article

Matsuzaki, Satoshi ; Szweda, Pamela A. ; Szweda, Luke I. ; Humphries, Kenneth M. / Regulated production of free radicals by the mitochondrial electron transport chain : Cardiac ischemic preconditioning. In: Advanced Drug Delivery Reviews. 2009 ; Vol. 61, No. 14. pp. 1324-1331.
@article{c88344d1d3ab4b1ca7e57f823408a63a,
title = "Regulated production of free radicals by the mitochondrial electron transport chain: Cardiac ischemic preconditioning",
abstract = "Excessive production of free radicals by mitochondria is associated with, and likely contributes to, the progression of numerous pathological conditions. Nevertheless, the production of free radicals by the mitochondria may have important biological functions under normal or stressed conditions by activating or modulating redox-sensitive cellular signaling pathways. This raises the intriguing possibility that regulated mitochondrial free radical production occurs via mechanisms that are distinct from pathologies associated with oxidative damage. Indeed, the capacity of mitochondria to produce free radicals in a limited manner may play a role in ischemic preconditioning, the phenomenon whereby short bouts of ischemia protect from subsequent prolonged ischemia and reperfusion. Ischemic preconditioning can thus serve as an important model system for defining regulatory mechanisms that allow for transient, signal-inducing, production of free radicals by mitochondria. Defining how these mechanism(s) occur will provide insight into therapeutic approaches that minimize oxidative damage without altering normal cellular redox biology. The aim of this review is to present and discuss evidence for the regulated production of superoxide by the electron transport chain within the ischemic preconditioning paradigm of redox regulation.",
keywords = "Cardiac ischemia, Electron transport chain, Free radicals, Mitochondria, Oxidation and reduction, Preconditioning",
author = "Satoshi Matsuzaki and Szweda, {Pamela A.} and Szweda, {Luke I.} and Humphries, {Kenneth M.}",
year = "2009",
month = "11",
day = "30",
doi = "10.1016/j.addr.2009.05.008",
language = "English (US)",
volume = "61",
pages = "1324--1331",
journal = "Advanced Drug Delivery Reviews",
issn = "0169-409X",
publisher = "Elsevier",
number = "14",

}

TY - JOUR

T1 - Regulated production of free radicals by the mitochondrial electron transport chain

T2 - Cardiac ischemic preconditioning

AU - Matsuzaki, Satoshi

AU - Szweda, Pamela A.

AU - Szweda, Luke I.

AU - Humphries, Kenneth M.

PY - 2009/11/30

Y1 - 2009/11/30

N2 - Excessive production of free radicals by mitochondria is associated with, and likely contributes to, the progression of numerous pathological conditions. Nevertheless, the production of free radicals by the mitochondria may have important biological functions under normal or stressed conditions by activating or modulating redox-sensitive cellular signaling pathways. This raises the intriguing possibility that regulated mitochondrial free radical production occurs via mechanisms that are distinct from pathologies associated with oxidative damage. Indeed, the capacity of mitochondria to produce free radicals in a limited manner may play a role in ischemic preconditioning, the phenomenon whereby short bouts of ischemia protect from subsequent prolonged ischemia and reperfusion. Ischemic preconditioning can thus serve as an important model system for defining regulatory mechanisms that allow for transient, signal-inducing, production of free radicals by mitochondria. Defining how these mechanism(s) occur will provide insight into therapeutic approaches that minimize oxidative damage without altering normal cellular redox biology. The aim of this review is to present and discuss evidence for the regulated production of superoxide by the electron transport chain within the ischemic preconditioning paradigm of redox regulation.

AB - Excessive production of free radicals by mitochondria is associated with, and likely contributes to, the progression of numerous pathological conditions. Nevertheless, the production of free radicals by the mitochondria may have important biological functions under normal or stressed conditions by activating or modulating redox-sensitive cellular signaling pathways. This raises the intriguing possibility that regulated mitochondrial free radical production occurs via mechanisms that are distinct from pathologies associated with oxidative damage. Indeed, the capacity of mitochondria to produce free radicals in a limited manner may play a role in ischemic preconditioning, the phenomenon whereby short bouts of ischemia protect from subsequent prolonged ischemia and reperfusion. Ischemic preconditioning can thus serve as an important model system for defining regulatory mechanisms that allow for transient, signal-inducing, production of free radicals by mitochondria. Defining how these mechanism(s) occur will provide insight into therapeutic approaches that minimize oxidative damage without altering normal cellular redox biology. The aim of this review is to present and discuss evidence for the regulated production of superoxide by the electron transport chain within the ischemic preconditioning paradigm of redox regulation.

KW - Cardiac ischemia

KW - Electron transport chain

KW - Free radicals

KW - Mitochondria

KW - Oxidation and reduction

KW - Preconditioning

UR - http://www.scopus.com/inward/record.url?scp=71549152199&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=71549152199&partnerID=8YFLogxK

U2 - 10.1016/j.addr.2009.05.008

DO - 10.1016/j.addr.2009.05.008

M3 - Review article

C2 - 19716389

AN - SCOPUS:71549152199

VL - 61

SP - 1324

EP - 1331

JO - Advanced Drug Delivery Reviews

JF - Advanced Drug Delivery Reviews

SN - 0169-409X

IS - 14

ER -